DART NEUROSCIENCE (CAYMAN) LTD.;HELICON THERAPEUTICS INC.
发明人:
申请号：
IL20391010
公开号：
IL203910A
申请日:
2010.02.11
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
The invention provides a compound of formula I: wherein A 1 , A 2 , A 3 , R 1 , X , Y , and B have any of the values described herein, as well as salts of such compounds, compositions comprising such compounds, and therapeutic methods that comprise the administration of such compounds. The compounds are inhibitors of monoamine oxidase B (MAO-B) enzyme function and are useful for improving cognitive function and for treating psychiatric disorders in animals.
